Clinical Trial Update: Clinical Trial of Pegylated Interferon α-2b Via Nebulization for Treatment of Hand, Foot, and Mouth Disease . [NA]

View source ↗

Summary

A clinical trial is evaluating pegylated interferon α-2b delivered by nebulization for hand, foot, and mouth disease and enrollment is currently recruiting. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease

Drugs mentioned

• Pegylated Interferon α-2b via Nebulization (pegylated interferon alpha-2b)

Snippet

Sponsor: Zhengzhou Children's Hospital, China | Conditions: HFMD | NA | Status: RECRUITING